Riyadh - Sharikat Mubasher: The Global Health Exhibition 2025 witnessed the launch of venture capital (VC) funds exceeding SAR 1 billion aimed at advancing the biotechnology sector in Saudi Arabia.
The European-based biotechnology investment and advisory firm, GOLDTRACK Ventures, announced its plans to establish the Kingdom’s first Industrial Biotechnology Growth Fund valued at SAR 940 million, positioning itself as a strategic partner in advancing Vision 2030 and the National Biotechnology Strategy 2040.
The fund is currently being structured and is expected to be filed with the Capital Market Authority (CMA) by the end of 2025, with initial investments planned to begin in 2026.
It will focus on scaling local and global biotechnology enterprises that aim to expand initially into Saudi Arabia and the wider MENA region. Its investment scope will include the red, green, white, yellow, grey, blue, and golden sectors of biotechnology, with a focus on industrial applications, bio-based materials, agri-tech, and sustainable solutions aligned with national priorities.
On the other hand, IB Ventures launched a new VC fund to invest SAR 175 million in advancing the Saudi biotechnology sector. The Biotech Fund, launched in the presence of the Minister of Health, Fahad AlJalajel, marks a significant milestone in advancing the Kingdom’s leadership in life sciences and innovation under Vision 2030.
The Global Health Exhibition 2025 takes place in Riyadh from 27 to 30 October, gathering global leaders across public and private sectors to drive conversations and action around the future of care.
From advancing health equity and unlocking longevity solutions to scaling digital health innovations and integrating wellness into mainstream care, the event reflects the evolving priorities of health systems around the world.
